4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

8-K - Syra Health Corp (0001922335) (Filer)

8-K - Syra Health Corp (0001922335) (Filer)

10-Q - Syra Health Corp (0001922335) (Filer)

8-K - Syra Health Corp (0001922335) (Filer)

DEFA14A - Syra Health Corp (0001922335) (Filer)

DEF 14A - Syra Health Corp (0001922335) (Filer)

PRE 14A - Syra Health Corp (0001922335) (Filer)

8-K - Syra Health Corp (0001922335) (Filer)

10-Q - Syra Health Corp (0001922335) (Filer)

8-K - Syra Health Corp (0001922335) (Filer)

Q3 2025 Revenue of $1.7 MillionRevenue driven by 96% year-over-year growth in the Population Health segmentGross margin improved 300 basis points to 33% in Q3 2025 from 30% in Q3 2024Net loss decreased 46% year-over-yearEarnings per share improved to ($0.02) for Q3 2025 compared to ($0.6) for Q3 2024CARMEL, Ind., Nov. 12, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare solutions company dedicated to powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today its financial results for the third quarter ended September 30, 2025.

CARMEL, Ind., Nov. 5, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), a healthcare solutions company powering better health outcomes through innovative services and technology, announced today that it will report financial results for the three months ended September 30, 2025, on Wednesday, November 12, 2025. The results will be shared via press release before the market opens. About Syra Health Syra Health is a healthcare solutions company serving public and private healthcare organizations with innovative solutions that positively impac

CARMEL, Ind., Sept. 23, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare solutions company focused on improving health outcomes through innovative services and technology, announced today its participation in two Indiana healthcare conferences this fall: Indiana Public Health Association 2025 Annual ConferenceOctober 22, 2025 – Indianapolis, IndianaIndiana Hospital Association Annual MeetingNovember 4–5, 2025 – Indianapolis, IndianaAt both events, Syra Health leaders will be available to meet with healthcare executives, public

-       Revenue of $1.9 Million consistent with the year-ago period-       Revenue led by Population Health's growth up 197% compared to Q2 2024-       Gross Margin increases to 38.7%, up 2,090 basis points compared to Q2 2024-       Earnings per share for the second quarter of 2025 were ($0.01), compared to ($0.21) in the year-ago period CARMEL, Ind., Aug. 12, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the second quarter ended June 30, 2025.

CARMEL, Ind., Aug. 5, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for the three months ended June 30, 2025, on Tuesday, August 12, 2025. The results will be shared via press release before the market opens. About Syra Health Syra Health is a healthcare technology company powering better health in critical areas such as behavioral and mental health, population health, and the healthcare workforce. The company's leading-edge technology products and innovative services focus on p

CARMEL, Ind., July 17, 2025 /PRNewswire/ -- Syra Health (OTCQB:SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today it has been awarded a new contract with a major insurance provider to staff registered nurses to support specific health plans. Under the one-year agreement, worth up to $2.1 million, Syra Health will provide medical management nurses to work with healthcare providers and plan members. The nurses will assess medical needs, interpret benefits, and connect members to appropri

CARMEL, Ind., July 8, 2025 /PRNewswire/ -- Syra Health (OTCQB:SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today it has achieved ISO 27001 certification, the international standard for managing information security. This certification underscores Syra Health's commitment to data protection and security, particularly important for tools like Syrenity, the company's science-based and AI-backed mental and behavioral health app that collects and processes sensitive user information. "As mo

CARMEL, Ind., May 27, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that the Indiana Department of Administration in collaboration with the Family and Social Services Administration/Division of Mental Health and Addiction has recommended Syra Health for contract negotiations to implement Indiana's Child Mental Health Wraparound Access Site. The contract is valued at $5.8 million over three years, with an optional one-year extension. Syra has committed to subcontracting 23.5% of the total contract value to other Indian

CARMEL, Ind., May 20, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that its Board of Directors will begin a national search for a new Chief Executive Officer to succeed current CEO Dr. Deepika Vuppalanchi. Dr. Vuppalanchi will serve as interim CEO until a successor is appointed. This leadership transition is part of a strategic succession plan designed to position Syra Health for its next phase of grow

Revenue increase led by Population Health's 261% YoY Expansion Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY Continued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024 A conference call will be held today, Thursday, May 8, at 9:00 am ET CARMEL, Ind., May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the first quarter ended March 31, 2025.

CARMEL, Ind., May 20, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that its Board of Directors will begin a national search for a new Chief Executive Officer to succeed current CEO Dr. Deepika Vuppalanchi. Dr. Vuppalanchi will serve as interim CEO until a successor is appointed. This leadership transition is part of a strategic succession plan designed to position Syra Health for its next phase of grow

Revenue increase led by Population Health's 261% YoY Expansion Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY Continued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024 A conference call will be held today, Thursday, May 8, at 9:00 am ET CARMEL, Ind., May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the first quarter ended March 31, 2025.

Conference call will be held on Thursday, May 8, at 9:00 a.m. ET CARMEL, Ind., May 1, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for the three months ended March 31, 2025, on Thursday, May 8, 2025, before market open. The Company will host a conference call that same day, May 8, 2025, at 9:00 a.m. ET, to discuss the results. Interested parties can access the con

2024 Population Health Revenue Acceleration to 132% YoY Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth A conference call will be held today, Tuesday, March 11 at 9:00 am ET CARMEL, Ind., March 11, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for fourth quarter and full year ended December 31, 2024.

Conference call will be held on Tuesday, March 11 at 9:00 a.m. ET CARMEL, Ind., March 4, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for its fourth quarter and full year 2024 ended December 31, 2024, on Tuesday, March 11, 2025, before the market opens. The company will host a conference call that same day, March 11, 2025, at 9:00 a.m. ET, to discuss the results.

Achieved Net Revenue of $2.3 million, ~42% Growth Over the Prior Year Quarter Gross Margins Increased Following Shift in Operational Strategy Net Loss Narrowed to $417,535 ($0.06 per share), a Significant Improvement from the $1.39 million ($0.21 per share) Net Loss in Q2 of 2024 Aiming to Attain Profitability in 2025 through Targeted Revenue Growth and Cost-Efficiency Measures Conference call will be held today, Tuesday, October 29th at 9:00 AM ET CARMEL, Ind., Oct. 29, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company driving better health through impactful, innovative solutions, announced today its financial results for

In the news release, Syra Health To Discuss Third Quarter 2024 Financial Results, issued 22-Oct-2024 by Syra Health over PR Newswire, we are advised by the company that the webcast link listed in the second and fourth paragraphs was incorrect. The URL should read "https://syrahealth.com/ir/presentations/q3-2024-earnings-call" rather than "https://dev.syrahealth.com/ir/presentations/q3-2024-earnings-call" as originally issued inadvertently. The complete, corrected release follows: Syra Health To Discuss Third Quarter 2024 Financial Results Conference call will be held on Tuesday, October 29 at 9:00 AM ET CARMEL, Ind., Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra He

Conference call will be held on Tuesday, October 29 at 9:00 AM ET CARMEL, Ind., Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended September 30, 2024, on Tuesday, October 29, 2024, before the market opens. The Company has scheduled a conference call that same day, October 29, at 9:00 a.m. ET, to review the results. Interested parties can access the conference call

Conference call will be held today, Thursday, August 8 at 9:00 am ET CARMEL, Ind., Aug. 8, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company powering better health by providing meaningful solutions, announced today its financial results for the second quarter ended June 30, 2024. Q2 2024 Financial Highlights Revenue of $2.0 million in 2Q24 compared to $1.0 million in 2Q23.Gross margins in 2Q24 increased 468 basis points compared to 2Q23.High-margin business units, including Population Health, grew 347% and co

Conference call will be held on Thursday, August 8 at 9:00 AM ET CARMEL, Ind., Aug. 1, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended June 30, 2024, on Thursday, August 8, 2024, before the market opens. The Company has scheduled a conference call that same day, August 8, 2024, at 9:00 a.m. ET, to review the results. Interested parties can access the conference call via

Conference call will be held today, Thursday, May 9 at 9:00 am ET CARMEL, Ind., May 9, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today its financial results for the first quarter ended March 31, 2024. Q1 2024 Financial Highlights Revenue of $1.7 million in 1Q24 compared to $1.2 million in 1Q23.Business units excluding Healthcare Workforce grew 333% and comprised 19% of total revenues in 1Q24, vers

SC 13G - Syra Health Corp (0001922335) (Subject)